CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 4 Open-market sale Director sold 5,146 shares at $35.00 ($180,110)
- 4 Open-market sale CFO, EVP & Treasurer sold 18,386 shares at $34.95 ($642,591)
- 4 Open-market sale CFO, EVP & Treasurer sold 5,512 shares at $32.05 ($176,682)
- 4 Shares withheld for taxes EVP Corp Admin Center gave up 128 shares (to pay taxes)
- 4 Grant or award Director acquired 4,163 shares (grant or award)
- 4 Grant or award Director acquired 4,163 shares (grant or award)
- 4 Grant or award Director acquired 4,163 shares (grant or award)
- 4 Grant or award Director acquired 4,163 shares (grant or award)
- 4 Grant or award Director acquired 4,163 shares (grant or award)
- 4 Grant or award Director acquired 4,163 shares (grant or award)
- 4 Open-market sale Director sold 10,291 shares at $37.79 ($388,859)
- 4 Shares withheld for taxes EVP Corp Admin Center gave up 264 shares (to pay taxes)
- 4 Open-market sale Director sold 500 shares at an average $37.00 ($18,499)
- 4 Open-market sale Director sold 10,000 shares at $34.93 ($349,323)
- 4 Open-market sale CEO & Chief Scientific Officer sold 10,650 shares at $34.21 ($364,365)
- 4 Shares withheld for taxes CFO, EVP & Treasurer gave up 378 shares (to pay taxes)
- 4 Open-market sale CEO & Chief Scientific Officer sold 108,776 shares at an average $34.00 ($3,697,861)
- 4 Open-market sale Director sold 9,924 shares at $35.05 ($347,826)
- 4 Open-market sale CEO & Chief Scientific Officer sold 118,445 shares at an average $35.75 ($4,234,897)
- 4 Open-market sale Director sold 10,291 shares at $35.61 ($366,500)
Page 10 of 31 · 601 filings